Gainers and Losers: NGM Biopharmaceuticals, Cue Health, and Corcept Therapeutics Among the Top Movers in the Stock Market
The stock market can be a volatile and unpredictable place, with prices constantly fluctuating based on a variety of factors. Each day, there are winners and losers, and it’s important for investors to stay informed about these movements. In this article, we will take a closer look at some of the top gainers and losers in the stock market.
Gainers:
1. NGM Biopharmaceuticals (NASDAQ: NGM) – NGM Biopharmaceuticals saw its shares rise by an impressive 43.2% to $1.23 during Monday’s after-market session. With a market cap of $101.7 million, NGM Biopharmaceuticals is a company to watch out for.
2. Cue Health (NASDAQ: HLTH) – Cue Health experienced a significant increase in its share price, rising by 35.38% to $0.22. The market value of its outstanding shares is currently at $34.0 million.
3. Homology Medicines (NASDAQ: FIXX) – Homology Medicines saw its stock increase by 12.46% to $0.64. With a market value of $36.8 million, this biopharmaceutical company is making waves in the industry.
4. Cue Biopharma (NASDAQ: CUE) – Cue Biopharma also experienced a positive movement in its share price, rising by 10.05% to $2.9. With a market cap of $130.8 million, Cue Biopharma is attracting investor attention.
5. Cadrenal Therapeutics (NASDAQ: CVKD) – Cadrenal Therapeutics saw its shares increase by 9.68% to $0.78. With a market cap of $10.1 million, this company is making strides in the healthcare sector.
6. Biophytis (NASDAQ: BPTS) – Biophytis also experienced a positive movement in its share price, rising by 9.05% to $0.73. With a market cap of $7.1 million, Biophytis is a smaller player with significant potential.
Losers:
1. Corcept Therapeutics (NASDAQ: CORT) – Corcept Therapeutics saw a significant decrease in its share price, falling by 38.4% to $20.0 during Monday’s after-market session. With a market value of $2.0 billion, Corcept Therapeutics is a major player in the healthcare sector.
2. China SXT Pharmaceuticals (NASDAQ: SXTC) – China SXT Pharmaceuticals experienced a decline in its stock price, falling by 31.49% to $2.72. With a market cap of $1.5 million, this company is facing challenges in the market.
3. LumiraDx (NASDAQ: LMDX) – LumiraDx saw its shares decline by 23.45% to $0.05. With a market cap of $15.7 million, LumiraDx is navigating a challenging period.
4. Aditxt (NASDAQ: ADTX) – Aditxt stock fell by 23.45% to $5.06. With a market value of $2.2 million, Aditxt is facing some setbacks.
5. Fresh2 Group (NASDAQ: FRES) – Fresh2 Group also saw a decrease in its stock price, falling by 15.74% to $0.75. With a market value of $17.7 million, Fresh2 Group is facing some challenges.
6. Qilian Intl Hldg Gr (NASDAQ: QLI) – Qilian Intl Hldg Gr experienced a decline in its stock price, falling by 12.69% to $0.64. With a market value of $22.8 million, Qilian Intl Hldg Gr is working to rebound.
These are just a few of the gainers and losers in the stock market. It’s important for investors to conduct thorough research and analysis before making any investment decisions. The stock market is a dynamic and ever-changing environment, and staying informed is crucial for success.
Please note that this article was generated by Benzinga’s automated content engine and reviewed by an editor. Benzinga does not provide investment advice. All rights reserved.
